JPRN-UMIN000009262招募中未知
effects of Uric-acid-lowering agent, FebuxOstat on subclinical inflammation in patients with hyperuricemia (UFO study) - effects of Uric-acid-lowering agent, FebuxOstat on subclinical inflammation in patients with hyperuricemia (UFO study)
FO study Investigators0 个研究点目标入组 100 人开始时间: 2012年11月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •(1) patients with history of gout (2) patients with malignancy, or other serious illness (3) patients with allergy to febuxostat (4) patients treated with mercaptopurine or azathioprine (5) patients not recognized as appropriate to participate (6) patients under insulin treatment (7) serum creatinine levels higher than 1.5 mg/dl (8) patients with inflammatory disease such as rheumatic diseases or inflammatory bowel diseases
研究者
相似试验
已完成
不适用
Effects of febuxostat on serum uric acid and arteriosclerosis in allopurinol-treated hyperuricemia patients with chronic kidney diseaseHyperuricemia patients with chronic kidney disease G3a, G3bJPRN-UMIN000008909Department of Nephrology and Hypertension, Kawasaki Medical School50
已完成
不适用
Effect of febuxostat on serum uric acid and renal function in patients with hyperuricemia. -open label, active (allopurinol)-controlled clinical studyHyperuricemiaJPRN-UMIN000008727Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine100
已完成
4 期
Effect of febuxisostat on serum uric acid levels and endothelial function in patients with hyperuricemiaHyperuricemiaJPRN-UMIN000008753Department of Cardiovascular Medicine, Juntendo University School of Medicine10
招募中
4 期
To compare the efficacy & safety profile of Febuxostat with Allopurinol in local Pakistani hyperuricemic patients.HyperuricemiaACTRN12612000434897PharmEvo (Pvt.) Ltd.120
招募中
3 期
the effect of febuxostat in sepsisIRCT20230814059148N1Tabriz University of Medical Sciences40